Go to the list of all blogs
published in Blogs
Jul 30, 2026
Morgan Stanley (MS) Posts Record Q2 2026 Earnings on Surging Trading and Banking Revenue

Morgan Stanley (MS) Posts Record Q2 2026 Earnings on Surging Trading and Banking Revenue

Key Takeaways

  • Record revenue and earnings: Morgan Stanley posted net revenues of $21.3 billion and diluted earnings per share (EPS) of $3.46 for the second quarter of 2026, both all-time highs that handily exceeded analyst consensus estimates.
  • Equities trading surged 69%: Equity sales and trading revenue reached a record $6.3 billion, driven by heightened client activity amid global market volatility, geopolitical tensions, and shifting interest rate expectations.
  • Investment banking rebounded powerfully: Investment banking revenue jumped 58% year over year to $2.44 billion, fueled by a boom in mergers and acquisitions (M&A) and blockbuster initial public offerings (IPOs), including the SpaceX debut.
  • Wealth Management hit a milestone: The division attracted a record $148 billion in net new assets, pushing combined client assets across Wealth and Investment Management past the $10 trillion mark for the first time.
  • Profitability metrics strengthened: Return on tangible common equity (ROTCE) — a key measure of a bank's profitability from its core operations — reached 26.6%, while the efficiency ratio improved to 65% from 71% a year earlier.
  • Share buyback fell short of some expectations: The firm repurchased $1.5 billion in shares, below one analyst estimate of $1.8 billion, which contributed to a muted initial stock reaction despite the blockbuster results.

Why These Results Matter in Today’s Market

Morgan Stanley’s second-quarter 2026 results arrived at a pivotal moment for global financial markets. The first half of 2026 saw M&A activity surge to $2.8 trillion — the strongest first-half total since LSEG began tracking records in 1980 — while equity markets remained buoyant despite ongoing geopolitical tensions, persistent inflation concerns, and a more hawkish Federal Reserve stance. For Morgan Stanley, this environment created a tailwind across all three of its major business lines: Institutional Securities, Wealth Management, and Investment Management. The report matters not only because it reflects the health of Wall Street’s core profit engines — trading and dealmaking — but also because it showcases how Morgan Stanley’s diversified model, combining high-octane capital markets with steady fee-based wealth management income, performs under real-world stress and opportunity. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Breaking Down the Reported Numbers

Morgan Stanley reported net revenues of $21.3 billion for the second quarter ended June 30, 2026, a 27% increase from $16.8 billion in the same period a year ago. This result crushed the consensus analyst estimate of approximately $19.6 billion. Net income applicable to Morgan Stanley came in at $5.58 billion, or $3.46 per diluted share, up sharply from $3.54 billion, or $2.13 per share, a year earlier. Analysts had forecast EPS of roughly $2.93 to $2.94, meaning the bank delivered an earnings beat of approximately 18%.

The Institutional Securities division was the standout performer, generating record quarterly revenue of $11 billion — a 44.7% year-over-year jump. Equities trading revenue alone soared 69% to $6.3 billion, as market volatility tied to the U.S.-Iran conflict, oil price swings, and shifting Federal Reserve policy expectations drove heavy client hedging and portfolio repositioning. Fixed income net revenue rose 13%. Investment banking revenue reached $2.44 billion, up 58%, with advisory fees climbing to $798 million and both equity and fixed income underwriting significantly exceeding forecasts. Morgan Stanley served as lead underwriter on SpaceX’s record IPO, advised Fertitta Entertainment on its $17.6 billion acquisition of Caesars Entertainment, and acted as joint book-running manager on Alphabet’s equity capital raise. From what I see, the equities trading surge stands out as a direct reflection of client demand in uncertain times.

Wealth Management generated $8.9 billion in revenue, up from $7.8 billion a year ago. Net new assets reached a record $148 billion, far outpacing analyst expectations of around $55 billion to $67 billion. Over half of those inflows came through IPO-related activity in the workplace services channel. Total client assets in the wealth division rose 25% to $8.08 trillion, and combined with Investment Management, total client assets crossed the $10 trillion milestone. The firm’s Common Equity Tier 1 (CET1) ratio — a measure of a bank’s core capital strength — held steady at 14.8%. Return on equity (ROE) reached 20.7%, and ROTCE hit 26.6%, both comfortably above consensus estimates.

How the Market Reacted

Despite the overwhelmingly strong headline numbers, Morgan Stanley shares initially dipped approximately 1.2% in pre-market trading on July 15 before recovering to close roughly 1% higher at around $229.94. The mixed intraday action reflected a classic “buy the rumor, sell the fact” dynamic: the stock had already rallied roughly 28.5% year-to-date heading into the report, and peer banks including Goldman Sachs and JPMorgan Chase had already posted similarly robust results the day prior, reducing the element of surprise. One specific point of investor scrutiny was the firm’s $1.5 billion in share repurchases during the quarter, which fell short of KBW analyst Chris McGratty’s $1.8 billion estimate. The board did raise the quarterly dividend to $1.15 per share and reauthorized a $20 billion repurchase program, but those moves were largely anticipated. The broader takeaway, however, was that execution was strong across the board, and analyst commentary remained broadly constructive following the call.

What to Watch in the Second Half

Looking ahead, Morgan Stanley enters the second half of 2026 with considerable momentum, but several factors will determine whether the record-setting pace can be sustained.

First, the investment banking pipeline remains robust. The M&A environment continues to benefit from improving CEO confidence, a relatively accommodative regulatory backdrop, and strong equity market valuations that encourage dealmaking. The IPO calendar, headlined by the SpaceX debut, suggests that equity underwriting fees could remain elevated, though activity levels are inherently unpredictable and sensitive to sudden shifts in market sentiment or geopolitical stability.

Second, trading revenues — which reached an all-time high this quarter — are by nature volatile. Continued geopolitical friction, persistent inflation readings, and any Federal Reserve policy surprises could sustain elevated trading volumes, but a sudden calm in markets would present a tough comparison for the Institutional Securities division in the quarters ahead. I’m watching this closely as a potential driver of near-term results.

Third, the Wealth Management business is increasingly becoming the firm’s anchor. With $148 billion in net new assets this quarter and total client assets now above $10 trillion, the division provides a growing base of recurring fee income that can buffer against capital markets cycles. Investors should monitor net new asset trends, loan growth, and deposit costs in this segment for signs of sustained momentum or emerging pressure.

Finally, capital allocation will remain under the microscope. The $20 billion buyback authorization provides ample runway, but the pace of actual repurchases relative to market expectations — and whether the firm deploys capital toward acquisitions, as CEO Ted Pick has indicated is possible under strict criteria — will be a key narrative. Cost discipline, reflected in the improved 65% efficiency ratio, will also be watched closely as the firm balances investment in growth with profitability targets.

Refining Research with AI Tools

In my regular analysis of earnings seasons, I turn to Tickeron’s AI Screener to quickly filter opportunities and compare names like Morgan Stanley against peers using technical indicators and AI signals. It helps surface ideas that align with broader sector trends without replacing traditional due diligence.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: MS

MS's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for MS turned positive on August 06, 2026. Looking at past instances where MS's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 07, 2026. You may want to consider a long position or call options on MS as a result. In of 71 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

MS moved above its 50-day moving average on August 12, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MS advanced for three days, in of 357 cases, the price rose further within the following month. The odds of a continued upward trend are .

MS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 295 cases where MS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The 10-day moving average for MS crossed bearishly below the 50-day moving average on July 30, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.210) is normal, around the industry mean (4.288). P/E Ratio (17.580) is within average values for comparable stocks, (21.728). Projected Growth (PEG Ratio) (2.062) is also within normal values, averaging (1.677). Dividend Yield (0.019) settles around the average of (0.033) among similar stocks. P/S Ratio (4.708) is also within normal values, averaging (31.480).

Notable companies

The most notable companies in this group are Morgan Stanley (NYSE:MS), Goldman Sachs Group (NYSE:GS), Charles Schwab Corp (The) (NYSE:SCHW), Gold.com Inc. (NYSE:GOLD).

Industry description

These banks specialize in underwriting (helping companies with debt financing or equity issuances), IPOs, facilitating mergers and other corporate reorganizations and acting as a broker or financial advisor for institutions. They might also trade securities on their own accounts. Investment banks potentially thrive on expanding its network of clients, since that could help them increase profits. Goldman Sachs, Morgan Stanley and CME Group Inc are some of the largest investment banking companies.

Market Cap

The average market capitalization across the Investment Banks/Brokers Industry is 13.15B. The market cap for tickers in the group ranges from 13 to 928.5B. PKRSF holds the highest valuation in this group at 928.5B. The lowest valued company is BFCH at 13.

High and low price notable news

The average weekly price growth across all stocks in the Investment Banks/Brokers Industry was 2%. For the same Industry, the average monthly price growth was -0%, and the average quarterly price growth was -10%. CANG experienced the highest price growth at 37%, while ETOR experienced the biggest fall at -21%.

Volume

The average weekly volume growth across all stocks in the Investment Banks/Brokers Industry was 3%. For the same stocks of the Industry, the average monthly volume growth was 1% and the average quarterly volume growth was -53%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 64
P/E Growth Rating: 70
Price Growth Rating: 63
SMR Rating: 76
Profit Risk Rating: 85
Seasonality Score: -8 (-100 ... +100)
View a ticker or compare two or three
MS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a provider of diversified financial services including brokerage, investment management and venture capital services

Industry InvestmentBanksBrokers

Profile
Details
Industry
Investment Banks Or Brokers
Address
1585 Broadway
Phone
+1 212 761-4000
Employees
80000
Web
https://www.morganstanley.com
Interact to see
Advertisement
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Golar LNG (GLNG) has remained resilient in recent trading, hovering near the top of its 52-week range as investor interest in floating LNG infrastructure continues to build. The stock is underpinned by a deep FLNG order backlog, steady production from operating assets, and improving financial flexibility.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.